Stocks
Cara Therapeutics (CARA) Net margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | 6.23% | -383.0% | -199.2% | -565.2% | -565.2% | -948.6% | ||
| Changes by years, y/y, % | +541pp | -389pp | +184pp | -366pp | 0pp | +0.6% | |||
Cara Therapeutics. Net margin, %
Cara Therapeutics. Net margin, changes, pp
Cara Therapeutics (CARA) Net margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Net margin, % | ? | -454.0% | -576.1% | -1 076% | -1 076% | -1 438% | -948.6% | |
| Changes by years, y/y, % | -437pp | -368pp | -176pp | -176pp | -1 021pp | |||
| Changes by quarters, q/q, % | -38pp | -122pp | -500pp | 0pp | -361pp | |||
